---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-001537"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2024-10-16T23:59:59+00:00"
generated_at: "2026-05-30T13:38:42.536492+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lexaria raises $5M via registered direct offering and private placement of warrants

## Summary
- Gross proceeds of $5.0M from sale of 1,633,987 shares at $3.06/share plus 4,551,019 warrants exercisable at $3.06.
- Warrants exercisable only after stockholder approval; expire 5 years from approval date.
- Included cancellation of 2,917,032 outstanding warrants issued in April 2024.
- Net proceeds to be used for working capital and general corporate purposes.
- Placement agent H.C. Wainwright receives 7% cash fee and warrants for 57,190 shares at $3.825.

## SEC filing metadata
- accession: 0001640334-24-001537
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2024-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/0001640334-24-001537-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-001537
- JSON: https://secwatch.observer/filing/0001640334-24-001537.json
- Plain text: https://secwatch.observer/filing/0001640334-24-001537.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.